Infant Formula vs Follow-on vs FSMP vs Growing-up Milk: Which SFDA Category Is My Product?

Why the category is the first decision

Every requirement that follows in a Saudi market-entry file is downstream of one choice: which regulatory category the product belongs to. The category determines the governing standard (and therefore the compositional limits your formulation must meet), the evidence package SFDA expects, the mandatory statements and prohibitions on the Arabic label, and the claims you may legally make. A product built and labelled as one category, then reclassified by SFDA as another, does not need a small correction — it needs a different dossier, different label artwork, and sometimes a different responsible party. That is why classification is settled in writing, first, before formulation gap-analysis, before artwork, and before you appoint an importer.

Two ground rules make the rest of this guide work:

• Classify by regulatory category, not by age band or marketing name. Age is an input to the definition, not the definition itself. "Growing-up milk," "toddler milk," and "gentle formula" are commercial names, not regulatory categories.
• First match wins. The categories are applied in a fixed order (below). The first definition a product satisfies is its category — you do not get to pick the most convenient one.

The categories at a glance

The reference table below maps each category to its typical age band, its governing standard, and the defining feature that puts a product there. Ages are drawn from the definitions in GSO 2106:2021 (verified against the Arabic source text).

The decision tree (first match wins)

Work top to bottom and stop at the first match.

1. Is it a formula for special medical purposes — a product intended to manage a disease, disorder, or medical condition, used under medical supervision? → FSMP. This is true even for infants (allergy, prematurity, inborn errors of metabolism). Medical purpose beats age and beats milk base.
2. Is it a breast-milk substitute for infants aged 0–12 months, intended as the sole source of nutrition (fully meeting nutritional needs in the first 6 months)? → Infant formula. Governed by GSO 2106:2021, with the strictest composition, label, and marketing controls.
3. Is it a complementary / weaning food — not a milk substitute and not an FSMP (for example a cereal, purée, or snack for older infants and young children)? → Complementary food. A different standard applies (SFDA.FD 5002).

If a product is a milk-based food for the weaning phase used alongside complementary feeding, it is follow-on formula under GSO 2106:2021 — the milk-based sibling of infant formula that sits between steps 2 and 3.

Why "first match wins" matters

A milk-based product marketed for a 9-month-old with a cow's-milk-protein allergy is not a follow-on formula — the medical purpose in step 1 captures it first, so it is an FSMP. Run the tree in order.

Infant formula vs follow-on formula

These two are the pair most often confused, because both are milk-based and both are governed by GSO 2106:2021 — but the definitions are distinct.

• Infant formula is a breast-milk substitute specially manufactured to be the sole source of nutrition for infants in the first six months of life, continuing with appropriate complementary feeding up to about 12 months. It is the category the WHO Code and the strictest marketing rules are built around.
• Follow-on formula is a milk-based food for the weaning phase, intended for infants from six months and used alongside solid complementary foods rather than as the sole source of nutrition.

The practical consequence: the two are not interchangeable on one dossier. Composition limits, the mandatory label statements, and the permitted claims differ, and a follow-on formula may not be presented in a way that implies it is suitable from birth. Treating "0–6" and "6+" products as one SKU family with a shared label is a recurring, avoidable rejection cause.

When it's an FSMP (used under medical supervision)

A formula for special medical purposes is intended for infants with special nutritional or medical needs that ordinary infant formula cannot meet — for example extensively hydrolysed or amino-acid formulas for cow's-milk-protein allergy, preterm formulas, or products for specific metabolic disorders. GSO 2106:2021 defines FSMP for infants across the 0–12-month range and subjects it to special-medical-purposes provisions.

The classifying feature is medical purpose and supervised use, not the ingredient list. If the product is designed to be used under the direction of a physician or other health professional to manage a condition, it is an FSMP — which is why it takes precedence at the very top of the decision tree. Because FSMPs carry a distinct evidence burden (clinical/medical substantiation, condition-specific labelling, and controls on how they are presented to healthcare professionals), Mayar Vision treats FSMP topics as part of its Medical Nutrition work, even for infant-aged products.

Where growing-up / toddler milks sit

This is the genuine grey zone, and it deserves an honest answer rather than a confident one. "Growing-up milk" and "toddler milk" (typically marketed for 12–36 months) are commercial categories, not standalone regulatory ones. Two facts pull in different directions:

• GSO 2106:2021's follow-on-formula definition already extends to 36 months — so a milk-based, weaning-phase product for a 12–36-month child can read as follow-on formula under GSO 2106.
• At the same time, a product positioned as an ordinary young-child food rather than a weaning formula could be argued into the complementary-foods standard.

Because the standards overlap in the 12–36-month band, the placement of a specific growing-up milk is a classification question to resolve with SFDA on the facts of the product — its composition, presentation, and claims — not a decision to make from the marketing brief. We flag this openly rather than assert a category.

How the category changes the standard, label, and permitted claims

Classification is not an academic exercise — it changes three concrete things:

1. The governing standard and composition limits. Infant formula, follow-on formula, and FSMP each meet different compositional requirements within GSO 2106:2021; complementary foods answer to a separate standard. Your formulation is measured against the limits for the declared category.
2. The mandatory label statements and prohibitions. Infant formula carries the heaviest label load — a breastfeeding-superiority notice, a health-worker-advice statement, pictorial preparation instructions with a hygiene warning, and prohibitions on infant images and wording that likens the product to breast milk (in Arabic «للاستخدام البشري» and «أمومة», or other similar expressions, per GSO 2106:2021 cl. 22.8.3). Follow-on formula and complementary foods carry a different set; an FSMP adds condition-specific and supervised-use statements. General labelling (GSO 9:2022) applies to all, but the product-specific standard prevails where they differ.
3. The permitted claims. What you may say about the product is category-bound. Breast-milk-substitute marketing is separately and heavily restricted (reflecting the WHO Code and the SFDA guide on handling breast-milk substitutes); an FSMP's claims are tied to its medical purpose and evidence; a complementary food follows the ordinary nutrition/health-claim rules. A claim that is fine for one category can be prohibited for another.

For the full registration and label mechanics of the infant-formula category, see our pillar guide, SFDA infant formula registration in Saudi Arabia, and the practitioner primer on SFDA registration vs import clearance. For the label fields common to every category, see SFDA label-compliance basics.

Still unsure which category applies?

Classification turns on the specific facts of the finished product — its composition, its intended user and age, whether it is a sole source of nutrition, whether it is used under medical supervision, and what it claims. When two categories could plausibly fit, the safe move is to resolve it before you commit to artwork or a dossier.

Not sure whether your product is infant formula, follow-on formula, an FSMP, or a complementary food under SFDA rules? Tell us the intended age group, whether the product is a sole source of nutrition or used under medical supervision, the milk base and full formulation, and the claims you plan to make, and we will map the likely category and the requirements that follow before you invest in artwork or testing.

Regulatory notice

This guide provides general regulatory information based on public sources and on the GSO 2106:2021 category definitions, checked on 9 August 2026. It is not legal advice, an SFDA decision, or a substitute for product-specific classification and review of the current applicable standards, circulars, and requirements. Standards and their Saudi adoption can change; confirm the current position before submission, printing artwork, or shipping.